Aptevo Therapeutics Inc. (APVO): It appears the offering was priced fairl...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	427
Posts	26003
Boards Moderated	6
Alias Born	09/26/2009

ErnieBilco

Re: None

Wednesday, 08/02/2023 2:18:29 PM

Wednesday, August 02, 2023 2:18:29 PM

It appears the offering was priced fairly, did not drop as far as I expected.

Added in all accounts

Bullish

Well that didn't go the way I expected

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent APVO News

Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 01:56:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 10:05:14 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:12:11 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:07:18 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2024 01:30:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 01:15:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:37:01 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 11:04:47 PM
Form DEFR14A - Revised definitive proxy soliciting materials • Edgar (US Regulatory) • 01/30/2024 01:00:01 PM
Form DEFR14A - Revised definitive proxy soliciting materials • Edgar (US Regulatory) • 01/16/2024 09:15:01 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/22/2023 09:15:04 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/12/2023 09:19:01 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/01/2023 05:15:15 AM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/22/2023 09:05:53 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 10:17:58 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 08:15:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/15/2023 08:30:09 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/10/2023 08:10:17 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/10/2023 08:07:27 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/10/2023 12:44:12 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/10/2023 12:41:08 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 12:30:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 12:16:52 PM
Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 08/03/2023 09:21:24 PM

More APVO News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover